Prominent among these is A20, which tempers NF‐κB signaling—a key pathway in IBD development—by removing K63‐linked polyubiquitin chains from NF‐κB signaling factors like NEMO, RIPK1, and TRAF6, thus maintaining immune homeostasis.32 This evidence concerns the gene NFKB1 and inflammatory bowel disease.